WEAVER CONSULTING GROUP Bristol-Myers Squibb Company Transaction History

WEAVER CONSULTING GROUP portfolio value:

$396,000
portfolio value

WEAVER CONSULTING GROUP quarter portfolio value change:

-7.68%
quarter

Bristol-Myers Squibb Company 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -0.05% -3 shares -33K $71.09 5.57K
Q2 2022 share Decrease -7.92% -480 shares -13K $77 5.57K
Q1 2022 share 0.00% 0 shares 64K $73.03 6.05K
Q4 2021 share Decrease -5.42% -347 shares -1K $62.52 6.05K
Q3 2021 share Increase +4.30% 264 shares -31K $59.17 6.40K
Q2 2021 share Increase +14.98% 800 shares 73K $65.79 6.14K
Q1 2021 share Decrease -3.63% -201 shares -7K $62.15 5.34K
Q4 2020 share Decrease -3.28% -188 shares -1K $60.6 5.54K
Q3 2020 share Decrease -4.64% -279 shares -8K $58 5.72K
Q2 2020 share 0.00% 0 shares 18K $56.14 6.00K
Q1 2020 share Increase +1.73% 102 shares 35K $52.79 6.00K
Q4 2019 share 0.00% 0 shares 37K $60.36 5.90K
Q3 2019 share Increase +3.51% 200 shares 4K $47.3 5.90K
Q2 2019 share 0.00% 0 shares -4K $41.93 5.70K
Q1 2019 share Increase 0.00% 5.70K shares 263K $43.73 5.70K